ArticleCancer immunology, immunotherapy : CII2023

Evaluation of the clinical molecule anti-human-PD-L1/IL-15 KD033 in the human-PD-1/PD-L1-expressing murine model demonstrates PD-L1 targeting of IL-15 in vivo.

Stella A Martomo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.